One mechanism of GLP-1 RA medications central to weight loss and glycaemic control is slowing of the emptying of gastric contents from the stomach
Though fucoxanthin is unstable, the factors contributing to its instability has been thoroughly studied
This was long after GLP-1s had garnered significant public interest, as seen in the below Google Trends chart
In response, enteroendocrine cells upregulate GLP-1 secretion, and GLP-1 receptor activation has been shown to suppress pro-inflammatory cytokines and macrophage infiltration
Not medical advice just a development I find fascinating and will be watching closely.Full papers here: Eshraghi et al., 2025, eClinicalMedicine: doi.org/10.1016/j.ecli Woo et al., 2026: doi.org/10.1111/acer.7 Jerlhag, 2025: doi.org/10.1210/endocr The reward pathway angle is what makes this interesting GLP-1 seems to be dampening the dopamine response to alcohol, not just reducing appetite for it
But patches are different